Melanoma Diagnostic Provider, Mela Sciences Provides Details Of Recent $12.45 Million Private Placement
IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ:MELA), (the Company) developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, today filed a Form 8-K providing full details from its recent Private Placement. Following is the text of the details relating to the private placement that were provided in the Form 8-K.
Help employers find you! Check out all the jobs and post your resume.